NM_004366.6:c.2003C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004366.6(CLCN2):​c.2003C>G​(p.Thr668Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.524 in 1,613,082 control chromosomes in the GnomAD database, including 229,465 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T668I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.54 ( 23661 hom., cov: 33)
Exomes 𝑓: 0.52 ( 205804 hom. )

Consequence

CLCN2
NM_004366.6 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 1.49

Publications

36 publications found
Variant links:
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
CLCN2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy with mild cerebellar ataxia and white matter edema
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • epilepsy, idiopathic generalized, susceptibility to, 11
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • familial hyperaldosteronism type II
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.0687833E-6).
BP6
Variant 3-184353275-G-C is Benign according to our data. Variant chr3-184353275-G-C is described in ClinVar as Benign. ClinVar VariationId is 217776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004366.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN2
NM_004366.6
MANE Select
c.2003C>Gp.Thr668Ser
missense
Exon 17 of 24NP_004357.3
CLCN2
NM_001171087.3
c.1952C>Gp.Thr651Ser
missense
Exon 17 of 24NP_001164558.1
CLCN2
NM_001171089.3
c.2003C>Gp.Thr668Ser
missense
Exon 17 of 23NP_001164560.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN2
ENST00000265593.9
TSL:1 MANE Select
c.2003C>Gp.Thr668Ser
missense
Exon 17 of 24ENSP00000265593.4
CLCN2
ENST00000344937.11
TSL:1
c.1952C>Gp.Thr651Ser
missense
Exon 17 of 24ENSP00000345056.7
CLCN2
ENST00000430397.5
TSL:1
n.*469C>G
non_coding_transcript_exon
Exon 7 of 13ENSP00000396231.1

Frequencies

GnomAD3 genomes
AF:
0.545
AC:
82836
AN:
152014
Hom.:
23634
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.684
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.459
Gnomad EAS
AF:
0.0969
Gnomad SAS
AF:
0.460
Gnomad FIN
AF:
0.411
Gnomad MID
AF:
0.558
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.538
GnomAD2 exomes
AF:
0.473
AC:
118966
AN:
251278
AF XY:
0.481
show subpopulations
Gnomad AFR exome
AF:
0.685
Gnomad AMR exome
AF:
0.324
Gnomad ASJ exome
AF:
0.477
Gnomad EAS exome
AF:
0.101
Gnomad FIN exome
AF:
0.426
Gnomad NFE exome
AF:
0.555
Gnomad OTH exome
AF:
0.501
GnomAD4 exome
AF:
0.522
AC:
762052
AN:
1460948
Hom.:
205804
Cov.:
56
AF XY:
0.521
AC XY:
378757
AN XY:
726846
show subpopulations
African (AFR)
AF:
0.679
AC:
22724
AN:
33474
American (AMR)
AF:
0.335
AC:
15003
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.472
AC:
12334
AN:
26132
East Asian (EAS)
AF:
0.0694
AC:
2754
AN:
39696
South Asian (SAS)
AF:
0.474
AC:
40850
AN:
86244
European-Finnish (FIN)
AF:
0.432
AC:
23005
AN:
53250
Middle Eastern (MID)
AF:
0.516
AC:
2978
AN:
5768
European-Non Finnish (NFE)
AF:
0.550
AC:
611666
AN:
1111284
Other (OTH)
AF:
0.509
AC:
30738
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
20485
40970
61455
81940
102425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16912
33824
50736
67648
84560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.545
AC:
82902
AN:
152134
Hom.:
23661
Cov.:
33
AF XY:
0.530
AC XY:
39424
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.684
AC:
28393
AN:
41522
American (AMR)
AF:
0.431
AC:
6589
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.459
AC:
1591
AN:
3470
East Asian (EAS)
AF:
0.0967
AC:
499
AN:
5160
South Asian (SAS)
AF:
0.462
AC:
2230
AN:
4824
European-Finnish (FIN)
AF:
0.411
AC:
4343
AN:
10566
Middle Eastern (MID)
AF:
0.572
AC:
166
AN:
290
European-Non Finnish (NFE)
AF:
0.553
AC:
37580
AN:
67980
Other (OTH)
AF:
0.532
AC:
1123
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1877
3754
5631
7508
9385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.508
Hom.:
5541
Bravo
AF:
0.551
TwinsUK
AF:
0.541
AC:
2005
ALSPAC
AF:
0.553
AC:
2132
ESP6500AA
AF:
0.680
AC:
2994
ESP6500EA
AF:
0.550
AC:
4729
ExAC
AF:
0.489
AC:
59427
Asia WGS
AF:
0.318
AC:
1112
AN:
3478
EpiCase
AF:
0.553
EpiControl
AF:
0.559

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Leukoencephalopathy with mild cerebellar ataxia and white matter edema Other:1
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.3
DANN
Benign
0.65
DEOGEN2
Benign
0.070
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.041
T
MetaRNN
Benign
0.0000041
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.47
N
PhyloP100
1.5
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.92
N
REVEL
Benign
0.16
Sift
Benign
0.83
T
Sift4G
Benign
0.78
T
Polyphen
0.0
B
Vest4
0.031
MutPred
0.23
Loss of glycosylation at P667 (P = 0.0121)
MPC
0.26
ClinPred
0.0018
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.025
gMVP
0.23
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9820367; hg19: chr3-184071063; COSMIC: COSV55599274; COSMIC: COSV55599274; API